OCON Medical develops, manufactures and commercialises innovative womens health products based on IUB™, its proprietary intrauterine platform. The platform, made of a super-elastic alloy Nitinol, is an ideal carrier for hormone-free contraception and intrauterine drugs.
OCONs first product, IUB™ SCu300 Intrauterine Ball, is a copper-based hormone-free intrauterine contraceptive. The IUB™ SCu300 is CE approved and available in 17 countries across Europe, South Africa and Israel.
The Company is also developing a strong pipeline of products using the IUB™ frame for hormonal contraception and additional indications including abnormal uterine bleeding and infertility.
OCONs shareholders include:
- Insud Pharma
OCONs technology platform and products are protected by a broad portfolio of patents and trademarks. The private Company, established in 2011, is headquartered in Modiin, Israel.